We are live on ! Find out more
KIC

Kensington Investment Counsel Portfolio holdings

AUM $208M
1-Year Est. Return 11.99%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+11.99%
3 Year Est. Return
+61.57%
5 Year Est. Return
10 Year Est. Return
AUM
$127M
AUM Growth
+$8.4M
Cap. Flow
+$62.7K
Cap. Flow %
0.05%
Top 10 Hldgs %
28.14%
Holding
82
New
1
Increased
18
Reduced
42
Closed
1

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$256K
2
CLX icon
Clorox
CLX
+$225K
3
OMCL icon
Omnicell
OMCL
+$160K
4
USB icon
US Bancorp
USB
+$149K
5
CFLT
Confluent
CFLT
+$132K

Sector Composition

Rank Sector Weight
1 Technology 24.01%
2 Healthcare 20.48%
3 Industrials 15.61%
4 Consumer Staples 11.79%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MORN icon
26
Morningstar
MORN
$7.41B
$1.93M 1.52%
8,913
NDAQ icon
27
Nasdaq
NDAQ
$53.5B
$1.93M 1.51%
31,379
+16
+0.1% +$997
TXN icon
28
Texas Instruments
TXN
$253B
$1.88M 1.48%
11,395
+172
+2% +$28.7K
CPRT icon
29
Copart
CPRT
$26.8B
$1.78M 1.4%
58,464
FIVE icon
30
Five Below
FIVE
$13.2B
$1.74M 1.36%
9,816
JPM icon
31
JPMorgan Chase
JPM
$971B
$1.7M 1.33%
12,651
-315
-2% -$39.9K
MKL icon
32
Markel Group
MKL
$22.8B
$1.67M 1.31%
1,268
TTD icon
33
Trade Desk
TTD
$6.34B
$1.62M 1.27%
36,155
PG icon
34
Procter & Gamble
PG
$335B
$1.59M 1.25%
10,479
-380
-3% -$53.3K
RGEN icon
35
Repligen
RGEN
$9.35B
$1.58M 1.24%
9,313
QQQ icon
36
Invesco QQQ Trust
QQQ
$481B
$1.54M 1.21%
5,797
+445
+8% +$123K
EW icon
37
Edwards Lifesciences
EW
$53.6B
$1.5M 1.18%
20,168
-333
-2% -$25.7K
BCPC
38
Balchem Corp
BCPC
$5.73B
$1.47M 1.15%
12,000
UNH icon
39
UnitedHealth
UNH
$364B
$1.42M 1.12%
2,677
-112
-4% -$59.3K
USB icon
40
US Bancorp
USB
$101B
$1.39M 1.09%
31,865
-3,490
-10% -$149K
LKQ icon
41
LKQ Corp
LKQ
$6.25B
$1.38M 1.09%
25,928
-40
-0.2% -$2.12K
DHR icon
42
Danaher
DHR
$145B
$1.37M 1.08%
5,826
-199
-3% -$46.1K
ITW icon
43
Illinois Tool Works
ITW
$83.3B
$1.35M 1.06%
6,117
-72
-1% -$15.3K
CLX icon
44
Clorox
CLX
$12.8B
$1.27M 1%
9,047
-1,585
-15% -$225K
RMD icon
45
ResMed
RMD
$32.8B
$1.27M 0.99%
6,079
NVS icon
46
Novartis
NVS
$290B
$1.25M 0.98%
13,790
-486
-3% -$40.9K
TECH icon
47
Bio-Techne
TECH
$11.3B
$1.23M 0.97%
14,864
GOOGL icon
48
Alphabet (Google) Class A
GOOGL
$4.2T
$1.18M 0.93%
13,384
+51
+0.4% +$4.85K
BMY icon
49
Bristol-Myers Squibb
BMY
$130B
$1.17M 0.92%
16,299
-92
-0.6% -$6.94K
H icon
50
Hyatt Hotels
H
$16.8B
$1.16M 0.91%
12,852
-20
-0.2% -$1.84K

Similar funds

Kensington Investment Counsel's Q4 2022 Portfolio in Review

As of Q4 2022, Kensington Investment Counsel held 82 positions worth $127M, up 7.1% from $119M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 2.4%. Kensington Investment Counsel opened 1 new position and exited 1, leaving the 82-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Kensington Investment Counsel's largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 754 shares worth $289K.
  • Kensington Investment Counsel added most to McCormick & Company Non-Voting in Q4 2022, an estimated $1.66M increase.
  • Kensington Investment Counsel's biggest Q4 2022 reduction was Clorox, cutting an estimated $225K.
  • Kensington Investment Counsel fully exited Meta Platforms (Facebook) in Q4 2022, selling an estimated $256K.
  • Kensington Investment Counsel's ten largest holdings make up 28% of its $127M portfolio in Q4 2022.
  • Kensington Investment Counsel opened 1 new position and closed 1 in Q4 2022.
  • Kensington Investment Counsel's portfolio value rose 7.1% quarter-over-quarter to $127M.

Based on Kensington Investment Counsel's 13F filing for Q4 2022, filed 15 Feb 2023.